epirubicin has been researched along with Uterine Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Z; Li, X; Wang, X; Xia, Y | 1 |
| Aukerman, SL; Brady, H; Chopra, R; Heise, C; Mamidipudi, V; Shi, T; Sung, V; Surapaneni, S | 1 |
| Ren, YL; Shen, L; Wang, HY; Yang, WT | 1 |
| Bamias, A; Bozas, G; Dimopoulos, MA; Gika, D; Kastritis, E; Markaki, S; Papadimitriou, CA; Rodolakis, A; Voulgaris, Z; Zorzou, MP | 1 |
| Fukunishi, H; Kitazawa, S; Takeuchi, S; Yukimura, N | 1 |
| Kitada, M; Sawaragi, I | 1 |
| Cannata, G; Gebbia, N; Gebbia, V; Testa, A | 1 |
| Fujimori, R; Sanada, H; Sekine, M; Serikawa, T; Shichiri, K; Tanaka, K | 1 |
| Freidlander, M; Hacker, NF; Manolitsas, TP; Wain, GV; Williams, KE | 1 |
| Argyle, DJ; Cave, TA; Hine, R; Howie, F; Thompson, H | 1 |
| Armas, A; Asins-Codoñer, E; Calero, F; Díaz-Castellanos, R; Garzón, J; Iglesias, J; Jimeno, J; Matía, F; Mendaña, J; Rodriguez Escudero, F | 1 |
| Antila, K; Eksborg, S; Stendahl, U | 1 |
4 trial(s) available for epirubicin and Uterine Neoplasms
| Article | Year |
|---|---|
[Clinical evaluation of granisetron hydrochloride against nausea and vomiting induced by anticancer drugs for gynecological malignant tumors].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1996 |
[Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting | 1998 |
Multimodality therapy for patients with clinical Stage I and II malignant mixed Müllerian tumors of the uterus.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Humans; Hysterectomy; Middle Aged; Mixed Tumor, Mullerian; Ovariectomy; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 2001 |
Pharmacokinetics of 4' epi-adriamycin after morning and afternoon intravenous administration.
Topics: Aged; Analysis of Variance; Biological Availability; Carcinoma; Circadian Rhythm; Epirubicin; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Random Allocation; Sarcoma; Uterine Neoplasms | 1989 |
8 other study(ies) available for epirubicin and Uterine Neoplasms
| Article | Year |
|---|---|
Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of TP53 Gene Therapy.
Topics: Adenoviridae; Adult; Bleomycin; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Genetic Therapy; Humans; Liver Neoplasms; Middle Aged; Progression-Free Survival; Recombinant Proteins; Sarcoma; Tumor Suppressor Protein p53; Uterine Neoplasms | 2018 |
Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cells.
Topics: Anthracyclines; Antineoplastic Agents; Breast Neoplasms; Caspase 3; Cell Growth Processes; Cell Line, Tumor; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; M Phase Cell Cycle Checkpoints; Ovarian Neoplasms; Topoisomerase II Inhibitors; Uterine Neoplasms | 2012 |
[Clinical and pathologic analysis of 33 cases of uterine papillary serous carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Endometrial Neoplasms; Epirubicin; Female; Humans; Hysterectomy; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Staging; Retrospective Studies; Survival Rate; Uterine Neoplasms | 2006 |
Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: long-term results of a single institution experience.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Staging; Sarcoma; Survival Analysis; Treatment Outcome; Uterine Neoplasms | 2007 |
Uterine myxoid leiomyosarcoma and CYVADIC-etoposide therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Epirubicin; Etoposide; Fatal Outcome; Female; Humans; Hysterectomy; Immunohistochemistry; Leiomyosarcoma; Lung Neoplasms; Mitotic Index; Treatment Outcome; Uterine Neoplasms; Vincristine | 1994 |
Treatment of cisplatin-related nausea and vomiting with a combination of ondansetron and metoclopramide: a pilot study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Ovarian Neoplasms; Pilot Projects; Prednisolone; Uterine Neoplasms; Vinblastine; Vinorelbine; Vomiting | 1996 |
Uterine carcinoma in a 10-month-old golden retriever.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Dog Diseases; Dogs; Epirubicin; Female; Uterine Neoplasms | 2002 |
Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the Grupo Ginecologico Español para el Tratamiento Oncologico (GGETO).
Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Endometrium; Epirubicin; Female; Humans; Middle Aged; Neoplasm Staging; Prognosis; Uterine Neoplasms; Vagina | 1991 |